Including the present case, only a few reports have described LDLT for adult patients with PPH [27–29] and a few reports have described a combination use of PDE5 inhibitor (sildenafil) and other drugs as bridging therapy in LDLT [30–33]. The gene discussed is PDE5A; the disease is pulmonary arterial hypertension.